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Abstract   
 
 
 
Introduction   
 
As a prevalent disease in women of childbearing age, treatment of leiomyoma is an area with 
many options.  Hysterectomy is a common and definitive treatment but is not appropriate in 
women wishing to attempt pregnancy.  Myomectomy surgically removes fibroids, and is the 
first line treatment for women wishing to preserve the uterus.  Uterine Artery Embolization 
(UAE) is an emerging treatment option with an uncertain effect on fertility.  As a less invasive 
procedure with good relief of symptoms and a shorter recovery period, UAE is appealing. The 
purpose of this review is to evaluate the current standing of UAE as a possible treatment option 
for women with leiomyoma wishing to preserve fertility.   
 
Methods   
 
This literature review focuses on studies published within the last ten years which report on 
pregnancies after UAE in women treated for uterine fibroids.  
 
Results   
 
Of the nine studies included, there are increased rates of spontaneous abortion, pre-term 
delivery, post-partum hemorrhage and abnormal placentation in a subset of the studies.  These 
results might be due to UAE or may perhaps be explained by the advanced maternal age of the 
subjects, or other subfertility factors not addressed in the studies.   
 
Conclusion   
 
The effects of UAE on subsequent pregnancy are still unclear.  The paucity of large 
randomized controlled trials and the small number of reported cases of pregnancy (less than 
200) limits the quality of the evidence.  Until larger randomized trials are completed comparing 
myomectomy and UAE, myomectomy will continue to be the first line therapy for women who 
intend to become pregnant.  Keywords:  leiomyoma, uterine artery embolization, pregnancy, 
fertility. 
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Preservation of Fertility after Uterine Artery Embolization:  A Review of 
Pregnancy Following Non-Surgical Intervention for Leiomyoma 
 
 
Introduction and Background 
 
 Uterine fibroids are a common benign tumor in women which increase in incidence 
with age.  It is thought that nearly 70% of Caucasian women can be affected by age 50, and 
they occur even more frequently and earlier in life in African American women.1  Abnormal 
uterine bleeding, pelvic pain and bloating, and urinary frequency are some of the predominant 
symptoms of leiomyomas, and if bleeding is excessive, anemia can result.   Hemorrhage, 
associated with hypervascularization, is the most common complication of leiomyomas.2  A 
uterus affected by fibroids can be the size equivalent of a uterus at 20 weeks of pregnancy.  
Little is known about the pathogenesis of leiomyomas, but the condition is thought to be 
influenced by genetic predisposition, steroid hormones and growth factors.  Over time, they 
will grow or shrink without intervention, and normally when hormone levels wane during 
menopause, they will shrink permanently. 
Leiomyomas develop in three distinct regions of the uterus:  the internal wall of the 
uterus (submucosal) where they can project into the intra-uterine space, within the muscle wall 
of the uterus (intramural or transmural), and on the external wall of the uterus (subserous).  
Intramural leiomyomas are the most common type of uterine fibroid.  The majority of 
leiomyomas are asymptomatic or will present with mild symptoms and do not require 
intervention.  Symptoms are classified into three categories:  increased uterine bleeding, bulk 
related symptoms (pelvic pressure and pain) and reproductive dysfunction.3  If symptoms are 
troublesome, therapy is guided by the size and location of the myoma, the nature of the 
symptoms, the patient’s age, obstetric history, and reproductive plans. 
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Fibroids themselves can contribute to infertility through several postulated mechanisms, 
and they account for between 1% and 2% of all cases of infertility.3  The location of the fibroid 
within the uterus, not its size, is thought to be the most important factor in terms of effect on 
fertility.  Leiomyomas which distort the internal cavity of the uterus, either submucosal or 
intramural, are associated with poor implantation, growth of the placenta over the myoma itself, 
rapid growth of fibroids in early pregnancy, and an increase in uterine contractility.4  It is also 
thought that fibroids may contribute to abnormal local endocrine patterns, chronic endometrial 
inflammation, and abnormal vascularization.5  The course of pregnancy is also adversely 
affected by the presence of submucosal or intramural fibroids, and is influenced by both size 
and location.   There is an increased risk of spontaneous abortion, first-trimester bleeding, 
breech presentation, c-section and placenta abruptio, all of which are worsened when the 
placenta is positioned over the myoma within the uterus.3 
Treatment for leiomyomas consists of several modalities:  medical hormone treatment, 
which seeks to shrink the fibroid in size, surgery (myomectomy, hysterectomy), which is 
accomplished through several different approaches and seeks to excise the fibroid(s), and 
uterine artery embolization, which cuts off blood supply to the fibroid, resulting in infarction of 
the tissue.  Myomectomy is the most common treatment for leiomyomas, but hysterectomy is 
considered the definitive treatment.  Fifty percent of hysterectomies in African American 
women are due to leiomyoma.3  If malignancy is suspected, surgery is indicated.  Other 
possible treatments include endometrial ablation, surgical uterine artery obstruction, magnetic 
resonance-guided focused-ultrasound surgery, and myolysis.   
Therapy choices are determined by the size and type of fibroid, whether  subserosal, 
intramural or submucosal.  Myomectomy is the only therapy appropriate for subserosal 
fibroids.  Uterine artery embolization (UAE) is not recommended in subserosal fibroids due to 
the risk of detachment from the uterus.  If the fibroid is less than 10 cm in diameter, and is 
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either intramural or subserosal, then laparoscopic myomectomy is possible.  Open (abdominal) 
myomectomy is needed if there are multiple myomas or if the diameter is greater than ten 
centimeters.  Myomectomy is associated with a small increased risk of uterine rupture during 
pregnancy, particularly if the uterine cavity is entered during the procedure, or if the 
practitioner has limited experience with laparoscopic suturing.  Hysteroscopic myomectomy is 
the approach used for submucosal fibroids.1   
When preservation of fertility is a concern for the patient, there are limited treatment 
choices.  Hormonal therapy is not appropriate during conception and pregnancy.  Hysterectomy 
is not an option.  Although myomectomy is the standard of care, there is an increased risk of 
miscarriage, uterine rupture, adhesion formation, intra-operative hysterectomy due to 
hemorrhage, and fibroid recurrence.1  For women with cavity-distorting fibroids, myomectomy 
increases conception rate, and the patient can attempt conception relatively soon after the 
procedure.3   Uterine artery embolization is an emerging alternative to myomectomy, but there 
is limited information as to fertility, with fewer than 200 documented cases of pregnancy 
following UAE. 
Uterine Artery Embolization 
Embolization as a general obstetric procedure was first developed in the 1970s as a 
means of achieving hemostasis in patients with post-partum hemorrhage.  By 1995, uterine 
artery embolization was being explored as a less invasive alternative to surgery for 
leiomyomas.2  Arteriography allows the radiologist to visualize the pelvic arterial tree and 
identify areas of tumor hypervascularization.  The patient is sedated and given prophylactic 
ceftriaxone beforehand; the procedure takes between 60 and 90 minutes, and no sutures are 
required.  Introducing particulate material into the arteries supplying the leiomyoma produces 
ischemic change to the fibroid without permanently damaging the uterus itself.  As the fibroid 
dies, the blood supply to the uterus is maintained through collateral vascularization.6 
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An interventional radiologist, well-trained in the technique, performs the procedure.  A 
catheter is passed into the common femoral artery (usually the right) and then into the 
contralateral internal iliac artery, and finally into the uterine artery.  Particles of either 
polyvinyl alcohol microspheres (500-700 micrometers), gelatin-coated tris-acryl microspheres, 
or other embolic materials are administered until occlusion is achieved in the appropriate 
vessels.  The ipsilateral uterine artery can be catheterized and embolized without withdrawing 
the catheter through the use of the Waltman’s loop, a radiologic technique developed in the 
1970s.7  Occasionally, the arteries will spasm during the procedure, and this is relieved with 
antispasmodic boluses delivered intra-arterially.7 
The risks of UAE include:  pelvic pain, hematoma at the injection site, need for re-
intervention (1 – 2.5%), chance of diminished ovarian reserve (1%),8  ovarian failure with 
amenorrhea (as high as 15%, but primarily in women over age 45),9 hemorrhage (0.15-- 
0.75%), and life threatening event (0.2 -- 0.5%).3  The rate for major complication is between 1 
and 5%, which is comparable to both myomectomy and hysterectomy.  The most common 
major adverse event is readmission to the hospital because of inadequately controlled post-
procedural pain.  There have been four reported deaths from complications after UAE, out of 
over 40,000 treated (this figure includes indications for UAE other than fibroids, such as post-
partum hemorrhage, adenomyosis, etc).  Two of these deaths were sepsis related, and two were 
due to pulmonary embolism.6  Post Embolization Syndrome (PES) is a well-documented 
cluster of symptoms including pain, fever, malaise, nausea and vomiting.  This phenomenon 
was more frequently seen in the past than it is today, mainly due to technical improvements to 
the procedure.6   
There are certain situations where UAE would be contraindicated for leiomyoma.  If a 
patient is immunosuppressed, suffers from severe vascular disease or has an allergy to contrast 
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media, they would not be a candidate for UAE.  Other contraindications include pregnancy, 
malignancy or infection.3 
One study reported that 1.1% of UAE patients go on to require a second surgical 
intervention within 30 days.9  These re-interventions can include repeat embolization, 
myomectomy, hysterectomy, dilation and curettage, and oophorectomy.  These risks are 
comparable to those of myomectomy.3 
UAE is successful in relieving symptomatic menorrhagia in 85% of cases, and 
improving pelvic discomfort secondary to myoma compression in between 30-60% of cases.9  
Post-procedural patient satisfaction is comparable to myomectomy.  Discharge and/or 
expulsion of the infarcted fibroid tissue can occur in either procedure.3  
For patients who are pursuing treatment for leiomyoma, there are some factors that 
drive the choice towards UAE and away from myomectomy.  Patients who wish to avoid intra-
abdominal surgery do well with UAE, as do patients who have undergone prior myomectomy.  
Previous abdominal surgery can leave extensive pelvic adhesions making subsequent 
myomectomy technically difficult.  Patients with large fibroid uteri (greater than 20 weeks 
gestational size) are at increased risk for hemorrhage or hysterectomy and can benefit from a 2 
step treatment.  Initially UAE is performed to decrease uterine volume, followed by 
myomectomy.10  A main advantage of embolization over myomectomy rests in the fact that in 
one procedure, all fibroids are treated.  Myomectomy treats only individual fibroids, and 
regrowth of fibroids after surgery is common.11  
As described in Up To Date, “the relationship between leiomyomas and infertility is 
controversial. Couples should complete a full infertility evaluation before addressing the role of 
leiomyomas in their infertility.”3  They recommend that women with asymptomatic myomas 
not postpone pregnancy, because both myomas and advancing maternal age can adversely 
affect fertility.  If the infertile patient has asymptomatic myomas that alter the shape of the 
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uterine cavity, however, myomectomy is recommended.  There are several retrospective 
observational studies which have concluded that removal of obstructing fibroids improves 
fertility.5  If the fibroids do not affect the uterine cavity, other causes of infertility should be 
addressed before pursuing myomectomy.3 
Managing fibroids during pregnancy can be a problem in itself.  Some fibroids increase 
in size during pregnancy, and large fibroids (>3 cm) are associated with adverse pregnancy 
events.  Surgical removal of fibroids during pregnancy is to be avoided due to risk of 
hemorrhage.  If the patient has had prior myomectomy or UAE, Up To Date recommends 
managing them as a prior cesarean patient.3  
Purpose of the study 
The purpose of this study is to clarify the effectiveness of uterine artery embolization in 
fertility preservation for women who undergo treatment for leiomyoma.  Among women whose 
fertility is a concern, current treatment guidelines for leiomyoma recommend myomectomy.3  
UAE is an alternative with shorter hospital stays, shorter recovery periods, and comparable 
rates of symptom reduction.  It is also a significantly less invasive procedure which makes it 
more appealing to patients.  Worldwide, estimates of UAE are around 40,000 for all 
indications, but the majority of these have been performed on women who are past their 
childbearing years.6  The aim of this literature review is to analyze and update information 
concerning this procedure with respect to fertility preservation.   There are fewer than 200 
reported cases of pregnancy after UAE, and these deserve analysis in the interest of guiding 
therapeutic recommendations for women with leiomyoma who still wish to have children. 
Methods 
 A comprehensive literature search was performed using the keywords:  leiomyoma, 
uterine artery embolization, pregnancy, fertility, embolization – therapeutic, leiomyoma – 
therapy, fertility, uterine neoplasms – therapy, and fibroid.  Medline, CINAHL, Evidence-
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Based Medicine Review Multifile, and Web of Science were the databases used.  Multiple 
databases were used in the interest of thoroughness, and literature was reviewed and included 
only if it held relevance to the topic.  As a procedure, UAE was only first described in 1995, 
and fertility results prior to 2000 are few.  In studies with serial results released every few years 
concerning a given patient population, only the most recent published articles were chosen in 
the interest of being as current as possible.  The results were then compiled and analyzed.  The 
inclusion criteria were English language articles that addressed issues of fertility after UAE in 
premenopausal women.  Papers were excluded if UAE had been used to treat conditions other 
than uterine fibroids (such as adenomyosis, uterine arteriovenous malformation, gestational 
trophoblastic disease, placenta accreta, etc).  Studies which focused only on outcomes of UAE 
not related to fertility, were likewise excluded.  The articles were reviewed and graded on the 
following criteria:  randomization, control group/intervention group, sample size, population, 
and outcomes reported.  Stronger studies gave details of maternal age, pregnancy history, time 
from UAE to pregnancy, outcome of pregnancy, gestational time, infant weight, and birth 
complications.   
Results 
A total of 9 articles are included, with publishing dates ranging from 2000 to June 2009.  
Publishing dates are generally several years after the date of embolization.  The time needed for 
a patient to conceive and deliver imposes a long timeline on this research, and several of the 
studies plan to publish as more pregnancies occur.  There was only one prospective randomized 
study (Mara et al, 2008), which compared UAE and myomectomy in randomized groups; the 
rest were retrospective or prospective studies.  One study compared patients receiving UAE 
with patients receiving laparoscopic uterine artery obstruction (LUAO), a procedure which cuts 
the artery medial to its origin from the hypogastric artery after either ultrasonic or bipolar 
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cauterization (Holub et al), but it was not randomized.  There were no studies comparing UAE 
with a group receiving no intervention.   
Mara et al (2008) examined the reproductive results in a study which randomized 121 
women with “fibroids and unfinished reproductive plans” to either UAE (n=58) or 
myomectomy (n=63) between 2001 and 2005.12  Out of 17 pregnancies in the UAE group, 5 
were completed at term, and the infants were of normal size.  The spontaneous abortion rate in 
the UAE group was 64% compared to 23% in the myomectomy group.  42% of the participants 
in the study had another subfertility factor other than myoma, making the results difficult to 
interpret.  There was one instance of postpartum hemorrhage, but no other complications were 
recorded.12  
Firouznia et al (2009) reported on 15 pregnancies in Iran after UAE for uterine fibroids.  
Of the 23 women treated who were seeking to become pregnant, 14 succeeded, with one 
subject being pregnant twice.  Two miscarriages occurred, both in women 41 years of age, and 
one infant was low birthweight, but this conception was only 2 months after UAE.  All 13 
births were by ceasarian delivery.  There was one case of postpartum hemorrhage caused by 
retained placental tissue.13  
Holub et al (2008) did a prospective cohort-controlled study in the Czech Republic 
which compared pregnancies after two different procedures for fibroids – UAE and LUAO 
(laparoscopic uterine artery occlusion).  In the UAE group, there were 28 pregnancies in 20 
women after a total of 112 underwent UAE, and 38 pregnancies after 225 LUAO  procedures.  
Although total group numbers were small, they found a 56% rate of spontaneous abortion in the 
UAE group, compared to 10.5% in the LUAO group, and both groups had increased risk of 
preterm birth and c-section.  Laparoscopic uterine artery occlusion is performed through the 
abdominal wall, placing vascular clips, sutures or using bipolar coagulation and working 
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external to the arteries, as opposed to working intravascularly to embolize the arteries as is 
done in UAE.14 
Pabon et al (2008) reported on 11 pregnancies in 10 women after UAE in 57 women 
wishing to preserve fertility.  In this group, where there had been no prior births, there were 8 
live births, and 3 spontaneous abortions.  Four were delivered vaginally, and four by c-section.  
Seven infants were of normal size and were delivered at term, 1 macrosomic infant was born 
pre-term at 33 weeks.15  
Walker et al (2006) report in the largest study to date, on 56 completed pregnancies 
after 1200 UAEs with one interventional radiologist performing all the procedures between 
1996 and 2005.  There were 33 successful live births in 27 different women in this UK study.  
Spontaneous abortions occurred in 30.4% of these pregnancies, and there were increased rates 
of c-section, preterm delivery, and postpartum hemorrhage compared to the general obstetric 
population.  Nineteen of those who became pregnant had prior subfertility, and there were 35 
first conceptions in this group.  81.8% of deliveries were at term, the rest were pre-term.  The 
average maternal age was 37.4 in this study.16  
Pron et al (2005) report on 24 pregnancies in 21 different women after 555 underwent 
UAE in Canada.  There were three cases of abnormal placentation (two with placenta previa, 
one with partial accreta) and another with placenta membranacea with accreta which resulted in 
cesarean hysterectomy.  There were three postpartum hemorrhages, all secondary to placental 
abnormalities, and four small for gestational age infants (less than 5th percentile), two of which 
were complicated with gestational hypertension.17  This study compared embolization and 
myomectomy, but the differences between the groups were found to be not statistically 
significant in a review article published in 2006.10 
Price et al (2005) contributed 2 cases of pregnancy after UAE in the UK, both c-section 
deliveries, one due to obstructing fibroids and one due to breech presentation.18  
 15 
McLucas et al (2001) report on 17 pregnancies in 14 women after UAE in 400 women, 
139 of whom expressed an interest in future fertility.  Women who were over 40 were excluded 
from the group included in the study, an unusual precedent in studies like this.  There were 10 
deliveries, and two on-going pregnancies at the time of publication.8  
Ravina et al (2000) report on 12 pregnancies in 9 women after UAE in a very early 
study reporting on pregnancy after UAE in France.  The mean maternal age was 38.19  
From Table 2 (page 23), it is evident that compared to the general obstetric population, 
risks are elevated in pregnancy after UAE for spontaneous abortion, cesarean delivery, pre-term 
delivery, and postpartum hemorrhage.  Malpresentation is not well reported in the literature, 
except when rates are high.  There was one study which had increased rates of small for 
gestational age infants.  Mean maternal age in these studies is higher than the general obstetric 
population, ranging from 32.2 to 38.5 compared to 27.4.  The sum total of pregnancies after 
UAE included here is 185, and the sum total of deliveries is 106.  Spontaneous abortion, 
elective termination, ectopic pregnancy, and pregnancies that were ongoing at the time of study 
publication account for the difference in these figures. 
Discussion 
 
The primary goal of this study was to identify trends in fertility after uterine artery 
embolization based on a review of current medical literature.  This discussion will focus on the 
outcomes reported, but due to the low quality of evidence, a limited number of reported cases, 
and a lack of homogeneity among study participants, no statistically significant trends are 
identified. 
 The rate of spontaneous abortion in patients after UAE is elevated across the board in 
these studies, ranging from 0 – 56%.  Interpreting these results is difficult, especially given the 
other possible factors contributing to spontaneous abortion.  The risk of spontaneous abortion is 
known to increase with age, from 9-17% in women between 20 and 30 years of age, to 20% at 
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age 35, 40% at age 40, and 80% at age 45.20   The average maternal age in the included studies 
ranges between 32.2 and 38.5.   Given the demographics of the population studied, the results 
are less surprising.   
In addition to maternal age, fibroid disease of the submucosal type as an independent 
disease entity increases the risk of spontaneous abortion.  It has been found that fibroids 
distorting the uterine cavity are more apt to produce this effect.21  The authors in the group 
reporting the highest rate of spontaneous abortion (56%) noted that the extent of fibroid 
disease, and the quality of myometrial perfusion are key factors in future pregnancies.14  These 
factors are not controlled for in these studies, and are therefore confounding variables. 
 The rate of cesarean delivery was also elevated across all the studies (47-100%) when 
compared to the normal obstetric population (31%).  There are several factors which play into 
this finding.  Current recommendations regarding pregnancy management after either UAE or 
myomectomy suggest managing this population in the same way as patients with prior cesarean 
section.3  Surgical myomectomy can weaken the uterine wall in the areas where fibroids are 
removed, a situation which is comparable to prior cesarean where the uterine wall is weakened 
at the incision site and confers an increased risk of rupture with subsequent pregnancies.  Given 
this obstetric strategy after myomectomy, it is appropriate that a similarly conservative 
approach is used in pregnancies after UAE, which is a relatively new and untried therapy.  It is 
therefore accurate to say that cesarean section often follows UAE, but is not caused by it. 
 Pre-term delivery appears to be nearly consistent with the normal obstetric population, 
as does the frequency of small for gestational age neonates.  These findings are reassuring 
given early fears that vascular supply to the developing fetus would be inadequate after 
embolization.  Neonates who were not premature met the CDC’s averages for birthweight.  
Three of the nine studies showed elevated rates of preterm delivery, two matched the normal 
rates, and there were 4 that fell below average. 
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 Postpartum hemorrhage is elevated (between 0 and 20%) in some of the studies, when 
compared to the normal obstetric population (8%).  It is worth noting that while these studies 
report on a given number of pregnancies, many do not progress to birth.  Therefore, in a study 
such as the Mara study with 26 pregnancies, there were only 5 births, and of these, there was 
one person with post-partum hemorrhage, which as a percent is expressed as 20%.  The Holub 
study also reports a 20% rate, but this represents only two out of ten deliveries.  Four of the 
studies report a 0% risk of hemorrhage, but clearly the numbers are too small to be conclusive. 
 Malpresentation and abnormal placentation are phenomena not well reported in the 
literature reviewed, except in studies where they were found to be noteworthy.  Many of the 
studies simply do not report on them.  Conclusions are not possible because of the small 
numbers of patients, and the inconsistency in the reporting on these variables.  Furthermore, as 
Holub notes, there are other “known risks for abnormal placentation [which] include advanced 
maternal age, multiparity, smoking, and prior cesarean delivery.”14 The Pron study makes the 
recommendation that placental status is closely monitored in these patients as a general 
precaution.17    
 All of these reported complications discussed above have multiple possible causes, 
UAE being only one.  Studies have shown that fibroid disease itself increases the risk of certain 
pregnancy complications even in untreated disease.  Risks of placental abruption, breech 
presentation, dysfunctional labor, and an increased risk of cesarean delivery have been 
documented, and risks are greatest when the placenta is implanted over the myoma within the 
uterus.3  Whether this relationship is causative, or the result of confounding factors is still 
unknown.   Thus, comparing pregnancy outcome after UAE to the general obstetric population, 
does not take into account the effects of the underlying disease. 
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Limitations of Study 
 
Although pregnancy provides a good measurable endpoint and a strong gauge of 
fertility, the pregnancy results in these studies are not interpretable in terms of pregnancy rate.  
In studies of fertility and infertility, pregnancy rate is defined as the success rate for pregnancy, 
expressed as a percentage of all attempts that lead to pregnancy per menstrual cycle.  We do not 
know what future pregnancies these patients might achieve, nor how many women actually 
tried to become pregnant between the date of their embolization and the publication date of the 
study.  A subset of the articles mention how many subjects stated an interest in having a baby at 
some point in the future, and still fewer address the number of study participants who were 
actively trying to conceive.  To measure fertility, given these constraints, is problematic:  we 
can say pregnancy is possible after UAE, but the data is insufficient to quantify in terms of 
fertility. 
The lack of homogeneity among subjects is another problem for interpretation.  Many 
of the women in these studies are already burdened with subfertility factors other than 
myoma.12  The degree of fibroid disease, prior obstetric history, advanced maternal age, 
possible spousal infertility, etc, are not controlled for, and are therefore confounding factors.   
The study sample sizes range from 2 to 56, with a total of 185 pregnancies and 106 
deliveries reported.  This number is lamentably small, and results in under-powered 
information, and limited statistical significance.  The studies with only one exception are either 
prospective or retrospective cohort studies, generally Level II-2 evidence. 
The Mara et al (2008) study done in Ireland, was the only randomized study which 
placed fibroid sufferers into either a myomectomy group or an embolization group.  There were 
40 pregnancies after 63 myomectomies, with a pregnancy rate of 63% compared with 26 
pregnancies after 58 embolizations, and a pregnancy rate of 45%.  The authors concluded that 
among women who plan to get pregnant shortly after their fibroid treatment, myomectomy is 
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the better procedure.12  A post-procedural waiting period of 6 months to a year is recommended 
after UAE for women attempting to conceive in order to allow fibroids to shrink and the uterus 
to revascularize.13  
Although leiomyoma are associated with between one and two percent of cases of 
infertility, there are no randomized controlled trials which demonstrate that myomectomy 
improves fertility in these women.5  There are many retrospective observational studies which 
support this view, however.  To properly analyze the effect of UAE (or myomectomy) on 
fertility, it would need to be compared to a control group, matched both in terms of age and 
extent of fibroid disease.  Whether this type of study could attract participants is questionable in 
a randomized controlled trial.  Women seeking help with fertility and significant fibroid disease 
are probably not willing to be left untreated in a control group.  Another difficulty in 
conducting research is the inherent variability of fibroid disease:  size, location and number of 
fibroids are interacting contributors to outcome.  Matching patients in terms of these variables 
is difficult within the structure of research design. 
Conclusion 
 
Leiomyoma confer a fertility burden on the female population of childbearing age in 
and of themselves.  Myomectomy is a procedure which, in select patients, decreases infertility, 
but it has a few grave risks which threaten fertility such as hemorrhage and hysterectomy.  In 
choosing a treatment designed to improve fertility, the patient actually risks complete 
infertility.  Finding alternative treatments for fibroids is clearly a valuable pursuit, but any new 
treatment must be measured against myomectomy, and proven to be as good or better.  There is 
only one RCT comparing UAE and myomectomy to date, and the small population size limits 
the power of this study. 
 With fewer than 200 documented cases of pregnancy following UAE and only 106 live 
births, the safety of the procedure cannot be established with respect to subsequent pregnancy.  
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The studies show higher rates of miscarriage and preterm delivery after UAE, but the 
interpretation of the data is limited because of the small number of patients, and advanced 
maternal age.  Larger studies with age-matched controls are needed before conclusions can be 
made regarding the possibility and safety of pregnancy after UAE.   
 A subset of the studies report postpartum hemorrhage and abnormal placentation as two 
complications of pregnancy which may be of concern after UAE.  Conservative management of 
these pregnancies is recommended while awaiting further research.  A conservative approach to 
pregnancies results in an increased rate of cesarean deliveries. 
Medical therapy for hormonal management of leiomyomas in women attempting to 
become pregnant is not recommended, and current recommendations favor myomectomy over 
UAE in this population, except in certain circumstances.  For women at high surgical risk, for 
example, those with extensive uterine leiomyomas presenting considerable surgical challenge, 
or those with previous abdominal laparotomy, UAE is the recommended procedure.3  
For many patients, the symptoms of leiomyoma intensify over time, and treatment may 
not even be considered until after the reproductive years are past.  In this population, there are 
many treatment options, and definitive treatment is tailored to the needs of the individual.  The 
patient who anticipates a reproductive future has fewer choices, however, and until more 
research is completed, first line treatment will continue to be myomectomy.    
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Table 1.  Literature review matrix 
Paper Study design Number of 
subjects/Population 
Inclusion criteria Results/Comments/Conclusions 
Firouznia 
2009 
Iran Prospective cohort 
study 
UAE in 102 women, 
23 with a stated 
interest in fertility 
Women seeking 
treatment for fibroid 
disease.  Desire to 
preserve fertility 
was not an 
exclusion criterion 
15 pregnancies in 14 women 
UAE “can serve as a substitute 
for invasive operations” 
Need for RCTs and more 
studies 
Mara et al 
2008 
Ireland 
Prospective 
Randomized Study 
UAE in 58 women,  
Myomectomy in 63 
women 
Fibroids > 4 cm in 
diameter 
All subjects have 
desire to preserve 
fertility 
26 pregnancies in 26 women 
Level I evidence 
The spontaneous abortion rate 
in the UAE group was 64% 
compared to 23% in the 
myomectomy group 
42% of the subjects had at 
least one other subfertility factor 
Pabon 
2008 
Spain Prospective cohort 
study 
UAE in 100 women, 
57 with a stated 
interest in fertility 
Women seeking 
treatment for fibroid 
disease.  Desire to 
preserve fertility 
was not an 
exclusion criterion 
11 pregnancies in 10 women 
Need for larger studies 
Holub 
2008 
Czech Republic 
Prospective 
multicenter cohort 
study 
UAE in 112 women, 
LUAO in 225 women 
(laparoscopic uterine 
artery occlusion) 
No randomization; 
treatment decision 
based on 
patient/doctor 
decision, of which no 
details are given 
Women seeking 
treatment for fibroid 
disease.   
28 pregnancies in 20 women in 
the UAE group 
Increased risk of spontaneous 
abortion in UAE group  (56%) 
compared to LUAO group 
(10.5%) 
Compared with pregnancies 
following LUAO, there were 
more cases of postpartum 
hemorrhage and 
malpresentation in the UAE 
group, but these were not 
statistically significant 
Walker 
2006 
United Kingdom Retrospective cohort 
study UAE in 1200 women 
Women seeking 
treatment for fibroid 
disease.   
56 pregnancies  
Increased risk of cesarean 
section, spontaneous abortion, 
preterm delivery, and 
postpartum hemorrhage 
compared to normal obstetric 
population 
Pron 
2005 
Canada Prospective multicenter cohort 
study 
UAE in 555 women 
Women seeking 
treatment for fibroid 
disease.   
24 pregnancies in 21 women 
Recommendation to monitor 
placental status throughout 
pregnancy 
High maternal age (average 36 
yrs) a confounding factors  
Price 
2005 
United Kingdom 
2 case reports 
Retrospective cohort 
Pregnancy reported in 
2 women after UAE 
Women seeking 
treatment for fibroid 
disease.  Prior UAE 
2 healthy infants in 2 
primigravid women 
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McLucas 
2001 
USA 
Prospective Cohort 
Study  
 
UAE in 400 women, 
139 women with 
stated interest in 
fertility 
Women selected for 
UAE fibroid 
treatment, only 
women <40 years 
old were included in 
study, a total of 52 
women 
17 pregnancies in 14 women  
10 normal term deliveries 
2 women still pregnant at 
publication time 
states no growth retardation, 
but no infant weights reported 
“Effect on fertility is comparable 
to myomectomy” 
Ravina 
2000 
France 
Prospective Cohort 
Study 
12 pregnancies in 9 
women following UAE 
after 184 
embolizations 
Women selected for 
UAE  fibroid 
treatment 
Preliminary study of fertility 
after UAE.  Author was the first 
to describe UAE for fibroids in 
the literature 
Pregnancies were 
serendipitous due to 
uncertainties of fertility, average 
maternal age 38 
Earliest UAE in this study was 
performed in 1988 for unknown 
indication, pt became pregnant 
2 yrs later, but advanced AIDS 
and streptococcal septicemia at 
28 wks complicated the 
pregnancy, she went into pre-
term labor, and infant died.  
Patient died a few mos later. 
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Table 2.  Pregnancy outcomes reported by study 
 
 
 
 
 
 
 
 
 
 
 
 
Lead author 
n = # of reported 
pregnancies 
Publication date 
CDC data 
general 
obstetric 
population 
20 
Firouznia 
(n=15) 
2009 
Mara 
(n=26) 
2008 
Pabon 
(n=11) 
2008 
Holub 
(n=28) 
2008 
Walker 
(n=56) 
2006 
Pron 
(n=24) 
2005 
Price 
(n=2) 
2005 
McLucas 
(n=15) 
2001 
Ravina 
(n=12) 
2000 
Mean maternal 
age 27.4 33.8 32.2 35.3 33.6 37.44 36 38.5 
Not 
reported 38 
Mean neonate 
weight (kg) 3.298 3.274 3.042 3.225 3.015 
 
3.53 
Premies 
1.692 
 
3.161 
Premies 
2.009 
3.283 Not reported 2.906 
Spontaneous 
abortion 10-15% 13% 64% 27% 56% 30% 17% 0% 33% 42% 
 
Delivery complications (expressed as a % of total deliveries) 
Preterm delivery 12.7% 0% 0% 13% 20% 18.2% 22% 0% 7% 12% 
Cesarean 
delivery 31% 100% 60% 50% 80% 73% 50% 100% 47% 62% 
Postpartum 
hemorrhage 4-6% 8% 20% 0% 20% 18% 16% 0% 0% 0% 
Malpresentation 6% Not reported 
Not 
reported 
Not 
reported 20% 
Not 
reported 
Not 
reported 50% 20% 
Not 
reported 
Small for 
gestational age 10% 8% 0% 0% 10% 3% 22% 0% 0% 0% 
Abnormal 
placentation Not reported 
Not 
reported 
Not 
reported 0% 0% 3% 12.5% 0% 7% 0% 
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Catheterization during uterine artery embolization 
 
Reprinted with permission of the Society of Interventional Radiology 2004, 2009, 
www.SIRweb.org. All rights reserved. 
 
 
 
 
Catheter tip position during uterine artery embolization 
 
Reprinted with permission of the Society of Interventional Radiology 2004, 2009, 
www.SIRweb.org. All rights reserved. 
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Pre-embolization angiogram of a patient with fibroids (Reprinted with permission from 
Madison Radiology) 
 
 
 
Post-embolization angiogram of the same patient (Reprinted with permission from Madison 
Radiology) 
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